Comparing two ways to give ondansetron for chemo nausea in kids
Part of Cancer, Digestive system clinical trials.
This trial compares two forms of ondansetron (a nausea medicine) — a dissolving film you put in the mouth versus a needle injection — to see which works better in preventing nausea and vomiting caused by chemotherapy in children with solid tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 months and 18 years old.
- They must have a solid tumor (not a blood cancer) and be about to start chemotherapy that causes moderate to severe nausea and vomiting.
- They should not have vomited in the 24 hours before chemo starts.
- They must not have certain heart rhythm problems or be on medicines that affect heart rhythm.
- They must not have used certain anti-nausea drugs or steroids recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two schedules of ondansetron (a nausea prevention drug) in people getting cisplatin chemotherapy plus a PD-1 inhibitor. It aims to find which dosing schedule works best to prevent nausea and vomiting.
This trial tests a new, easy-to-take film that melts on the tongue to prevent vomiting caused by radiation therapy in children with cancer. It may be a good option if your child is getting radiation to the belly or spine and has trouble swallowing pills.
This trial tests a medicine called IV NEPA (fosnetupitant/palonosetron) to prevent nausea and vomiting in children who are receiving strong chemotherapy. Patients will receive at least one cycle of chemotherapy that is highly likely to cause these side effects.
This trial tests a new injection, HSK21542, to see if it can prevent nausea and vomiting caused by strong chemotherapy drugs. It may help people who have never had chemo before.
This trial tests a new form of megestrol acetate to prevent nausea and vomiting caused by chemotherapy in people with advanced stomach cancer who haven't had chemo before. It's for those starting a specific chemo combo that includes a PD-1 inhibitor and CAPOX.
This trial tests if a medicine called dolasetron can prevent chemotherapy-related nausea and vomiting in children with acute lymphoblastic leukemia (ALL). It may help kids feel better during their first round of treatment.
Hear when a new Pediatric Solid Tumor, Unspecified, Protocol Specific trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.